Loading...
OTCM
OTCFF
Market cap33mUSD
Oct 20, Last price  
0.28USD
1D
0.90%
1Q
-17.82%
IPO
-32.93%
Name

Ocumetics Technology Corp

Chart & performance

D1W1MN
OTCM:OTCFF chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
133.35%
Shs. 5Y
110.02%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-5m
L+77.80%
-75,958-35,732-172,485-172,485-598,190-2,219,947-3,643,641-3,022,158-5,373,327
CFO
-3m
L+38.50%
-32,876-39,530-817-817-89,132-1,618,556-2,046,333-2,430,062-3,365,648

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.
IPO date
Aug 29, 2018
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
1250, 639 5th Avenue S.W.
Calgary, AB T2P 0M9
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑072020‑122020‑072019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT